User:Rithish Nimmagadda: Difference between revisions

Jump to navigation Jump to search
Line 28: Line 28:
#[[Mirikizumab-mrkz]]
#[[Mirikizumab-mrkz]]
#[[Bimekizumab]]
#[[Bimekizumab]]
#[[Lotilaner]]

Revision as of 16:58, 17 May 2024

<nowiki>

Your Name

Rithish Nimmagadda,MBBS

Research scholar
Contact:945-278-1660
Email: rithishnvs@gmail.com [1]

Current Position

  • research scholar (list chapters here)



Education

Medical Degree from Kamineni Academy of Medical sciences and research centre , Hyderabad , India



Pages Authored/Co-authored/Collaborated

  1. Epcoritamab-bysp
  2. Elfabrio
  3. Mirikizumab-mrkz
  4. Bimekizumab
  5. Lotilaner